Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,346,909 papers from all fields of science
Search
Sign In
Create Free Account
Chronic leukemia
Known as:
chronic leukemias
, Leukemia of unspecified cell type, chronic
, Chronic leukemia NOS
Expand
A slowly progressing leukemia characterized by a clonal (malignant) proliferation of maturing and mature myeloid cells or mature lymphocytes. When…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
Bone Marrow
Chronic disease
Hematopoietic and Lymphoid Cell
Hematopoietic and Lymphoid Tissue
Expand
Narrower (2)
Chronic Lymphocytic Leukemia
Myeloid Leukemia, Chronic
Broader (1)
leukemia
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2006
Review
2006
Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patients
R. Betts
,
A. Glasmacher
,
+7 authors
N. Kartsonis
Cancer
2006
Corpus ID: 45966476
Neutropenia is an indicator of poor prognosis in patients with fungal infections. All available clinical trial experience from…
Expand
Review
2004
Review
2004
Considerations for targeting malignant stem cells in leukemia.
M. Guzman
,
C. Jordan
Cancer Control: Journal of the Moffitt Cancer…
2004
Corpus ID: 25929606
BACKGROUND Malignant stem cells have been identified in acute myelogenous leukemia, chronic myeloid leukemia, and some types of…
Expand
Review
2001
Review
2001
Chronic myeloid disorders: Classification and treatment overview.
A. Tefferi
Seminars in hematology (Print)
2001
Corpus ID: 19806463
Highly Cited
1999
Highly Cited
1999
Preparation and evaluation of the rhenium-188-labelled anti-NCA antigen monoclonal antibody BW 250/183 for radioimmunotherapy of leukaemia
U. Seitz
,
B. Neumaier
,
G. Glatting
,
J. Kotzerke
,
D. Bunjes
,
S. Reske
European Journal of Nuclear Medicine
1999
Corpus ID: 11251765
Abstract. Anti-NCA antigen antibody BW 250/183 (Anti-Granulocyte) localizes more than 50% of injected antibody dose to the bone…
Expand
Review
1999
Review
1999
Allogeneic hematopoietic transplantation as adoptive immunotherapy. Induction of graft-versus-malignancy as primary therapy.
R. Champlin
,
I. Khouri
,
+5 authors
S. Giralt
Hematology/Oncology Clinics of North America
1999
Corpus ID: 2090996
Highly Cited
1998
Highly Cited
1998
The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemia
M. Lowdell
,
R. Craston
,
N. Ray
,
M. Koh
,
G. Galatowicz
,
H. Prentice
Bone Marrow Transplantation
1998
Corpus ID: 9561750
The prophylactic use of T cell depletion (TCD) strategies for the prevention of graft-versus-host disease (GVHD) following…
Expand
Review
1997
Review
1997
Functional aspects of apoptosis in hematopoiesis and consequences of failure.
S. McKenna
,
T. Cotter
Advances in Cancer Research
1997
Corpus ID: 25226972
Highly Cited
1993
Highly Cited
1993
Outcome for patients who relapse after allogeneic bone marrow transplantation for chronic myeloid leukemia. Chronic Leukemia Working Party. European Bone Marrow Transplantation Group
W. Arcese
,
J. Goldman
,
+7 authors
P. Ljungman
1993
Corpus ID: 208197852
We studied the clinical course of 130 chronic myeloid leukemia (CML) patients (89 males and 41 females) in the European Bone…
Expand
Highly Cited
1968
Highly Cited
1968
Studies of Muramidase (Lysozyme) in Leukemia
P. Perillie
,
S. Kaplan
,
E. Lefkowitz
,
William Rogaway
,
S. Finch
1968
Corpus ID: 71751328
The muramidase activity of serum, urine, and leukocytes was measured in a group of patients with acute and chronic leukemia…
Expand
Highly Cited
1954
Highly Cited
1954
Serum proteins in leukemia.
R. Rundles
,
E. Coonrad
,
T. Arends
American Journal of Medicine
1954
Corpus ID: 27467617
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE